BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8549175)

  • 1. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.
    Crausman RS; Lynch DA; Mortenson RL; King TE; Irvin CG; Hale VA; Newell JD
    Chest; 1996 Jan; 109(1):131-7. PubMed ID: 8549175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse cystic lung diseases: correlation between radiologic and functional status.
    Paciocco G; Uslenghi E; Bianchi A; Mazzarella G; Roviaro GC; Vecchi G; Harari S
    Chest; 2004 Jan; 125(1):135-42. PubMed ID: 14718432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyst-based measurements for assessing lymphangioleiomyomatosis in computed tomography.
    Lo P; Brown MS; Kim H; Kim H; Argula R; Strange C; Goldin JG
    Med Phys; 2015 May; 42(5):2287-95. PubMed ID: 25979023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst Ventilation Heterogeneity and Alveolar Airspace Dilation as Early Disease Markers in Lymphangioleiomyomatosis.
    Walkup LL; Roach DJ; Hall CS; Gupta N; Thomen RP; Cleveland ZI; McCormack FX; Woods JC
    Ann Am Thorac Soc; 2019 Aug; 16(8):1008-1016. PubMed ID: 31038987
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis.
    Avila NA; Kelly JA; Dwyer AJ; Johnson DL; Jones EC; Moss J
    Radiology; 2002 Apr; 223(1):189-97. PubMed ID: 11930066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.
    Schmithorst VJ; Altes TA; Young LR; Franz DN; Bissler JJ; McCormack FX; Dardzinski BJ; Brody AS
    AJR Am J Roentgenol; 2009 Apr; 192(4):1037-44. PubMed ID: 19304711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative CT analysis of small pulmonary vessels in lymphangioleiomyomatosis.
    Ando K; Tobino K; Kurihara M; Kataoka H; Doi T; Hoshika Y; Takahashi K; Seyama K
    Eur J Radiol; 2012 Dec; 81(12):3925-30. PubMed ID: 22964373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
    Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
    Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
    Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
    Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests.
    Avila NA; Chen CC; Chu SC; Wu M; Jones EC; Neumann RD; Moss J
    Radiology; 2000 Feb; 214(2):441-6. PubMed ID: 10671592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity.
    Crausman RS; Jennings CA; Mortenson RL; Ackerson LM; Irvin CG; King TE
    Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1368-76. PubMed ID: 8616568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT grading of lung disease in lymphangioleiomyomatosis.
    Yao J; Taveira-DaSilva AM; Colby TV; Moss J
    AJR Am J Roentgenol; 2012 Oct; 199(4):787-93. PubMed ID: 22997369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Hedin C; Stylianou MP; Travis WD; Matsui K; Ferrans VJ; Moss J
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1072-6. PubMed ID: 11587999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
    Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
    Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
    Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
    Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary lymphangioleiomyomatosis: analysis of disease manifestation by region-based quantification of lung parenchyma.
    Theilig D; Doellinger F; Kuhnigk JM; Temmesfeld-Wollbrueck B; Huebner RH; Schreiter N; Poellinger A
    Eur J Radiol; 2015 Apr; 84(4):732-7. PubMed ID: 25604910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangioleiomyomatosis.
    Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
    Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative computed tomography detects air trapping due to asthma.
    Newman KB; Lynch DA; Newman LS; Ellegood D; Newell JD
    Chest; 1994 Jul; 106(1):105-9. PubMed ID: 8020254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with emphysema: quantitative CT analysis before and after lung volume reduction surgery. Work in progress.
    Bae KT; Slone RM; Gierada DS; Yusen RD; Cooper JD
    Radiology; 1997 Jun; 203(3):705-14. PubMed ID: 9169692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative chest computed tomography as a means of predicting exercise performance in severe emphysema.
    Crausman RS; Ferguson G; Irvin CG; Make B; Newell JD
    Acad Radiol; 1995 Jun; 2(6):463-9. PubMed ID: 9419592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.